Announcements Trials

Browse Landscape

Phase

Phase 3 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1 Hematologic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Bronchiolitis Obliterans Syndrome 1 Anemia 1

Interventions

Darbepoetin alfa 19 Epoetin Alfa 17 ACE-011 4 Cyclosporine 3 Busulfan 3 luspatercept 2 fludarabine phosphate 2 fludarabine 2 ferric carboxymaltose 2 epoetin beta 2 continuous erythropoietin receptor activator 2 Methotrexate 2 Iron-Dextran Complex 2 Filgrastim 2 Cyclophosphamide 2 vactosertib 1 thymoglobulin 1 ruxolitinib 1 roxadustat 1 peginesatide 1 pegfilgrastim 1 niraparib 1 leridistim 1 iron isomaltoside 1000 1 hematide 1 ferric gluconate 1 eltrombopag 1 angiotensin I (1-7) 1 Therapeutics 1 Thalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anemia × Blood Transfusion × Clear all

NCT01116479 2014-11-05

HaemOPtimal

Rigshospitalet, Denmark

Phase 2 Terminated

Classical hematology

Anemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡